Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Diabetes Prevention in Clinical Practice. (DIAVIP)

This study has been completed.
Information provided by (Responsible Party):
Göteborg University Identifier:
First received: April 15, 2013
Last updated: August 22, 2016
Last verified: August 2016
We randomize individuals with impaired glucose tolerance to one of three arms for degree of physical activity: 1. Continue with your current life style; 2. Ordinary life activities for increased physical activity; 3. Scheduled group activities for changed behavior. The overall aim is to focus on change of physical activity and to keep other life style activities more or less unchanged (diet, smoking, etc) and the effect on metabolic variables.

Condition Intervention
Type 2 Diabetes
Behavioral: Low intensity intervention
Behavioral: High intensity intervention.

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Diabetes Prevention in Primary Health Care With Special Emphasis on Physical Activity.

Further study details as provided by Göteborg University:

Primary Outcome Measures:
  • HOMA IR [ Time Frame: 12 months after inclusion (baseline) ] [ Designated as safety issue: No ]
    Insulin resistance according to HOMA

Enrollment: 96
Study Start Date: October 2009
Study Completion Date: August 2016
Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: No intervention
Experimental: Low intensity intervention Behavioral: Low intensity intervention
We administer, a pedometer and the participants receive a prescription on physical exercise.
Experimental: High intensity intervention Behavioral: High intensity intervention.
We schedule group sessions for changes in behavior e.g. type of physical activity to prefer, barriers for change of life style etc.


Ages Eligible for Study:   20 Years to 85 Years   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Impaired glucose tolerance
  2. Age: 20-85yrs

Exclusion Criteria:

  1. Type2 diabetes
  2. Significant disease making life style changes unlikely to happen
  3. Unable to communicate in Swedish
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Göteborg University Identifier: NCT01834378     History of Changes
Other Study ID Numbers: DIAVIP-1204  Swedish Research Council 
Study First Received: April 15, 2013
Last Updated: August 22, 2016
Health Authority: Sweden: The National Board of Health and Welfare

Keywords provided by Göteborg University:
insulin resistance

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases processed this record on October 21, 2016